iuvo molecule

Clinical Research Team

With an expert team with more than 150 years combined clinical experience, iuvo shares your vision to develop new modalities and therapeutics for the treatment or management of ocular conditions.

Shannon Stoddard

Shannon Stoddard

President, Clinical Services

Shannon leads the Clinical Research team and is responsible for the overall operation and performance of the clinical research business, which includes: clinical operations, biostatistics, data management, medical/safety, project management, medical writing, and regulatory compliance.
 
Shannon is an experienced clinical research executive who brings more than 27 years of diverse experience to this role across various stages of device and drug development. During Shannon’s time at Promedica International (PMI), a California Corporation, she held the roles of clinical research coordinator, clinical research specialist, project manager, clinical trial manager, clinical service director, and VP clinical services and data management.
 
Shannon holds a BS in Civil Engineering from University of California, Irvine and a Master of Business from University of Phoenix.

Charles Slonim, MD

Charles Slonim, MD

Chief Medical Officer

Dr. Charles B. Slonim most recently served as an Professor of Ophthalmology and Affiliate Professor of Plastic Surgery at the University of South Florida College of Medicine in Tampa and Associate Clinical Professor of Ophthalmology at the University of Florida College of Medicine in Gainesville, Florida.

Dr. Slonim teaches physicians about ophthalmic and oculoplastic diseases, diagnoses, and surgeries, as well as contact lens technology. He has lectured extensively to ophthalmologists, optometrists, and other physicians throughout the United States, and in more than 55 international cities in more than 34 countries around the world. He served as a Consultant at the Olympic Vision Center in the Olympic Village during the 1992 Summer Olympics in Barcelona. He has been a world-renowned Consultant for a number of major contact lens and ophthalmic pharmaceutical companies. He served as the Medical Director for Bausch and Lomb Pharmaceutical, Inc. from 1990-2009 and as a Member for Scientific Advisory Board of Sirion Therapeutics, Inc. and Sirion Holdings Inc. He is the team Ophthalmologist for many Tampa Bay area professional and intercollegiate sports teams, including the Tampa Bay Lightning of the National Hockey League and the University of South Florida intercollegiate sports programs. He has published one book, Eye Was There: A Patient Guide to Coping with the Loss of an Eye, more than 50 scientific journal articles, 26 ophthalmic book chapters, and 11 clinical symposia.

Dr. Slonim has served as the Medical Monitor for more than 32 clinical trials from which NDA approvals for 10 drugs have been successfully rewarded.

Dr. Slonim is a graduate of Johns Hopkins University and New York Medical College and completed his Ophthalmology Residency from Mt. Sinai Medical Center in Cleveland, Ohio.

Roselyn Judd

Roselyn Judd

Director of Clinical Operations

Roselyn Judd has over 30 years of experience in ophthalmology and 25 years of experience in clinical research. She has been responsible for managing clinical trials for CROs, Pharmaceutical companies and academic institutions. Prior to joining Oculos, Roz was a Global Clinical Site Developer for Alcon, Clinical Trials Manager at Vanderbilt University and the Director of Clinical Operations at Sirion Therapeutics. In her current position, Roz is responsible for the overall study and resource management for Oculos.

Roz has her Bachelor of Science degree in Human Resource Development from Oakland University in Rochester, Michigan.

Esmeralda Cardosa

Esmeralda Cardosa

Associate Director, Clinical Technology

Ms. Cardosa has 13 years of clinical research experience and joined Oculos in January 2013. She has worked on pediatric and adult studies with indications of Dry Eye, Glaucoma, Post-Op Inflammation, Uveitis, ARMD, Amblyopia, Nasolacrimal Duct Obstruction, Esotropia, Leukemia and Lymphoma. Esmeralda has experience with case report form creation, remote electronic data monitoring, on-site monitoring, data verification and coding, site selection, maintenance regulatory files, study start up, investigator meeting preparations and managing central monitoring. She has earned her CCRP certification through SOCRA and is currently in the process of obtaining her Bachelor of Science Degree from the University of Central Florida.

Kathleen Krenzer, OD, PhD, DABT

Kathleen Krenzer, OD, PhD, DABT

Research Fellow - Toxicology

Dr. Kathleen Krenzer is a board-certified toxicologist (DABT) serving as a Research Fellow in toxicology, with a focus on ophthalmic product development.  Prior to joining iuvo, Kathleen was a Senior Principal Scientist at Bausch + Lomb in the non-clinical safety group.

Kathleen’s expertise in nonclinical product development stems from her previous experiences as a Study Director at a contract research laboratory, overseeing both pharmaceutical and medical device testing, and as a principal/senior principal scientist at Bausch + Lomb where she covered both pharmaceutical and medical device development programs, including 510(k), PMA, IND, and NDA submissions, geo-expansion activities, as well as nonclinical support for marketed products.

As a clinician-scientist, Kathleen brings a wealth of expertise in the area of ophthalmic product development, always maintaining focus on the ultimate beneficiary, the patient.  Her background in ophthalmic development includes early discovery with testing in efficacy models through clinical evaluations, having served as part of clinical investigative teams for numerous ophthalmic products.

Kathleen received her BS in Biology from the University of Notre Dame.  She earned her Doctor of Optometry degree (OD) from the New England College of Optometry, where she continues to serve as an adjunct professor, teaching in the College’s international programs.  She earned her PhD from Boston University School of Medicine in Pathology, focusing on ocular pathology and dry eye disease, and continued her post-doctoral training at the Schepens Eye Research Institute of Harvard University.